Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 RA for AF ablation outcomes in T2DM
NCT06660134Completed
- Sponsor
- Shanghai Chest Hospital
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by Shanghai Chest Hospital. Primary endpoint: Recurrence of atrial arrhythmias at 12 months. Started Aug 2021; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT06660134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06660134.